Terms: = Sarcomas AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Diagnosis
45 results:
1. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
2. Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literature.
Schaumann N; Bartels S; Kuehnle E; Kreipe H; Christgen M
Pathol Res Pract; 2024 Feb; 254():155100. PubMed ID: 38277744
[TBL] [Abstract] [Full Text] [Related]
3. SMARCB1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
4. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract] [Full Text] [Related]
5. idh-negative chondrosarcoma with metachronous dedifferentiation only in the metastatic site-A diagnostic pitfall.
Sekita T; Yoshida A; Kawai A; Ichikawa H; Kobayashi E
Genes Chromosomes Cancer; 2023 Dec; 62(12):755-760. PubMed ID: 37732625
[TBL] [Abstract] [Full Text] [Related]
6. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
7. Conventional chondrosarcoma of the rib cage and sternum: clinicopathological and molecular analysis of 27 patients treated at a single institution.
Abdulfatah E; Rottmann D; Morag Y; Pantanowitz L; Udager AM; Hao W; Lucas DR
Hum Pathol; 2023 Jun; 136():63-74. PubMed ID: 37019410
[TBL] [Abstract] [Full Text] [Related]
8. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
Fu L; Zhang Z; Chen Z; Fu J; Hong P; Feng W
Curr Treat Options Oncol; 2023 Apr; 24(4):338-352. PubMed ID: 36877373
[TBL] [Abstract] [Full Text] [Related]
9. Chondrosarcoma Skull Base: A Case Report.
Bharti JN; Elhence P; Bhaskar S; Garg PK
Curr Med Imaging; 2023; 19(11):1346-1350. PubMed ID: 36748815
[TBL] [Abstract] [Full Text] [Related]
10. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and immunohistochemical testing of bone tumours: review and update.
Kovacs SK; Manassaporn A; Nielsen GP; Hung YP
Histopathology; 2023 May; 82(6):794-811. PubMed ID: 36424903
[TBL] [Abstract] [Full Text] [Related]
12. Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Ball S; Knepper TC; Deutsch YE; Samra W; Watts JM; Bradley TJ; Chan O; Hussaini MO; Zhang L; Sweet KL; Kuykendall AT; Talati C; Padron E; Komrokji RS; Lancet JE; Sallman DA
Cancer; 2022 Nov; 128(21):3880-3887. PubMed ID: 36107670
[TBL] [Abstract] [Full Text] [Related]
13. Oligosarcomas, idh-mutant are distinct and aggressive.
Suwala AK; Felix M; Friedel D; Stichel D; Schrimpf D; Hinz F; Hewer E; Schweizer L; Dohmen H; Pohl U; Staszewski O; Korshunov A; Stein M; Wongsurawat T; Cheunsuacchon P; Sathornsumetee S; Koelsche C; Turner C; Le Rhun E; Mühlebner A; Schucht P; Özduman K; Ono T; Shimizu H; Prinz M; Acker T; Herold-Mende C; Kessler T; Wick W; Capper D; Wesseling P; Sahm F; von Deimling A; Hartmann C; Reuss DE
Acta Neuropathol; 2022 Feb; 143(2):263-281. PubMed ID: 34967922
[TBL] [Abstract] [Full Text] [Related]
14. The genetics of vascular tumours: an update.
Torrence D; Antonescu CR
Histopathology; 2022 Jan; 80(1):19-32. PubMed ID: 34958509
[TBL] [Abstract] [Full Text] [Related]
15. Osteosarcoma: Old and New Challenges.
Yoshida A
Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
[TBL] [Abstract] [Full Text] [Related]
16. Intracranial myeloid sarcoma presentation in distant acute myeloid leukemia remission.
Lee D; Omofoye OA; Karnati T; Graff JP; Shahlaie K
J Clin Neurosci; 2021 Jul; 89():158-160. PubMed ID: 34119261
[TBL] [Abstract] [Full Text] [Related]
17. Unexpected diagnosis of multiple sclerosing pneumocytomas in a patient with chondrosarcoma of the hand.
Van Laer SL; Vandendriessche A; Somville J; Van Schil PE
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33495182
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract] [Full Text] [Related]
19. Association of Clinicopathological Features With Outcome in Chondrosarcomas of the Head and Neck.
Asioli S; Ruengwanichayakun P; Zoli M; Guaraldi F; Sollini G; Greco P; Facco C; Gibertoni D; Jiménez BV; Benini S; Turri-Zanoni M; Pasquini E; Mazzatenta D; Foschini MP; Righi A
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):807-814. PubMed ID: 32928034
[TBL] [Abstract] [Full Text] [Related]
20. Synovial chondrosarcoma: a single-institution experience with molecular investigations and review of the literature.
Gambarotti M; Pacheco M; Ruengwanichayakun P; Silvino Vega Jiménez B; Benini S; Bianchi G; Sbaraglia M; Vanel D; Carretta E; Bertoni F; Franchi A; Dei Tos AP; Righi A
Histopathology; 2020 Sep; 77(3):391-401. PubMed ID: 32506447
[TBL] [Abstract] [Full Text] [Related]
[Next]